Françoise Brun‐Vézinet

14.8k total citations · 2 hit papers
207 papers, 9.8k citations indexed

About

Françoise Brun‐Vézinet is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Françoise Brun‐Vézinet has authored 207 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Virology, 161 papers in Infectious Diseases and 44 papers in Epidemiology. Recurrent topics in Françoise Brun‐Vézinet's work include HIV Research and Treatment (167 papers), HIV/AIDS drug development and treatment (147 papers) and HIV/AIDS Research and Interventions (107 papers). Françoise Brun‐Vézinet is often cited by papers focused on HIV Research and Treatment (167 papers), HIV/AIDS drug development and treatment (147 papers) and HIV/AIDS Research and Interventions (107 papers). Françoise Brun‐Vézinet collaborates with scholars based in France, United States and United Kingdom. Françoise Brun‐Vézinet's co-authors include Daniel R. Kuritzkes, Bonaventura Clotet, Victoria A. Johnson, Florence Damond, Diane Descamps, Douglas D. Richman, François Simon, Ibtissam Loussert-Ajaka, Jonathan Schapiro and Sophie Matheron and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Françoise Brun‐Vézinet

204 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a New Human Retrovirus from West African Patients with AIDS

1986 830 citations Françoise Brun‐Vézinet, M.A. Rey et al. profile →
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O

1998 391 citations François Simon, Philippe Mauclère et al. profile →

Peers

Countries citing papers authored by Françoise Brun‐Vézinet

Since Specialization

Citations

This map shows the geographic impact of Françoise Brun‐Vézinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Brun‐Vézinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Brun‐Vézinet more than expected).

Fields of papers citing papers by Françoise Brun‐Vézinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Brun‐Vézinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Brun‐Vézinet. The network helps show where Françoise Brun‐Vézinet may publish in the future.

Co-authorship network of co-authors of Françoise Brun‐Vézinet

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Brun‐Vézinet. A scholar is included among the top collaborators of Françoise Brun‐Vézinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Brun‐Vézinet. Françoise Brun‐Vézinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection 2019 ·PLoS Pathogens ·Assia Samri, Charlotte Charpentier, (unknown), Mélanie Bertine, (unknown), Véronique Morin, (unknown), Christophe Parizot, Gilles Collin, Anne Hosmalin, Rémi Cheynier, Rodolphe Thiébaut, Sophie Matheron, (unknown), Rima Zoorob, Françoise Brun‐Vézinet, Brigitte Autran, (unknown)	6
2	Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2–Infected Controllers 2016 ·The Journal of Immunology ·(unknown), Mathieu Angin, Glenn Wong, Laura Papagno, Pierre Versmisse, Annie David, Charles Bayard, (unknown), (unknown), Rodolphe Thiébaut, Faroudy Boufassa, Gianfranco Pancino, Delphine Sauce, Olivier Lambotte, Françoise Brun‐Vézinet, Sophie Matheron, Sarah Rowland‐Jones, Rémi Cheynier, Asier Sáez‐Cirión, Victor Appay	14
3	Isolation of a New Retrovirus in a Patient at Risk for Acquired Immunodeficiency Syndrome 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·J C Chermann, (unknown), C. Dauguet, Françoise Brun‐Vézinet, C. Rouzioux, Willy Rozenbaum, Luc Montagnier	2
4	In-vitro phenotypic susceptibility of HIV-1 ’non-B’ integrase inhibitors naive clinical isolates to dolutegravir and raltegravir 2013 ·AIDS ·Charlotte Charpentier, Mélanie Bertine, Benoît Visseaux, (unknown), Lucile Larrouy, Gilles Peytavin, Thomas Mourez, Gilles Collin, Françoise Brun‐Vézinet, Jean‐Christophe Plantier, Diane Descamps	6
5	Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients 2012 ·Journal of Antimicrobial Chemotherapy ·C. Charpentier, Lucile Larrouy, Benoît Visseaux, Roland Landman, (unknown), Alexandre Storto, Florence Damond, Yazdan Yazdanpanah, P. Yéni, Françoise Brun‐Vézinet, Diane Descamps	20
6	Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort 2011 ·AIDS ·Rodolphe Thiébaut, Sophie Matheron, Audrey Taïeb, Françoise Brun‐Vézinet, Geneviève Chêne, Brigitte Autran	25
7	Update of the Drug Resistance Mutations in HIV-1: December 2010 2010 ·PubMed ·Victoria A. Johnson, Françoise Brun‐Vézinet, Bonaventura Clotet, Huldrych F. Günthard, Daniel R. Kuritzkes, Deenan Pillay, Douglas D. Richman, (unknown)	71
8	Predictive Value of HIV‐1 Genotypic Resistance Test Interpretation Algorithms 2009 ·The Journal of Infectious Diseases ·Soo‐Yon Rhee, W. Jeffrey Fessel, Tommy F. Liu, Natalia Marlowe, Charles M. Rowland, Richard A. Rode, Anne–Mieke Vandamme, Kristel Van Laethem, Françoise Brun‐Vézinet, Vincent Cálvez, Jonathan Taylor, Leo B. Hurley, Michael A. Horberg, Robert W. Shafer	37
9	Molecular testing of multiple HIV-1 transmissions in a criminal case 2005 ·AIDS ·Philippe Lemey, Sonia Van Dooren, Kristel Van Laethem, Yoeri Schrooten, Inge Derdelinckx, Patrick Goubau, Françoise Brun‐Vézinet, Dolorès Vaira, Anne–Mieke Vandamme	32
10	HIV Type 1 Diversity in Northeastern Romania in 2000-2001 Based on Phylogenetic Analysis of pol Sequences from Patients Failing Antiretroviral Therapy 2003 ·AIDS Research and Human Retroviruses ·Cristian Apetrei, Diane Descamps, Gilles Collin, David L. Robertson, Ivona Pandrea, (unknown), (unknown), (unknown), (unknown), Françoise Brun‐Vézinet	10
11	Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen 2002 ·AIDS ·Vincent Le Moing, Geneviève Chêne, Patrizia Carrieri, Ahmadou Alioum, Françoise Brun‐Vézinet, Lionel Piroth, (unknown), Jean‐Paul Moatti, François Raffi, Catherine Leport	141
12	Phylogenetic Analysis of 49 Newly Derived HIV-1 Group O Strains: High Viral Diversity but No Group M-like Subtype Structure 2002 ·Virology ·Pierre Roques, David L. Robertson, Sandrine Souquière, Florence Damond, Ahidjo Ayouba, Isabelle Farfara, Christel Depienne, Eric Nerrienet, Dominique Dormont, Françoise Brun‐Vézinet, François Simon, Philippe Mauclère	51
13	Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study 2001 ·AIDS ·Diane Descamps, Vincent Cálvez, Jacques Izopet, Claudine Buffet‐Janvresse, (unknown), Philippe Colson, Annick Ruffault, Anne Maillard, Bernard Masquelier, Jacqueline Cottalorda, M Harzic, Françoise Brun‐Vézinet, Dominique Costagliola	30
14	HIV-1 diversity in France, 1996–1998 2000 ·AIDS ·Élisabeth Couturier, Florence Damond, Pierre Roques, Hervé Fleury, Françis Barin, Jean‐Baptiste Brunet, Françoise Brun‐Vézinet, François Simon	87
15	HIV Type 1 Diversity and the Reliability of the Heteroduplex Mobility Assay 1998 ·AIDS Research and Human Retroviruses ·Ibtissam Loussert-Ajaka, Elisabeth Menu, Cristian Apetrei, Martine Peeters, Florence Damond, Philippe Mauclère, Josef Eberle, Cécile Brengues, Sentob Saragosti, Françoise Barré‐Sinoussi, Françoise Brun‐Vézinet, François Simon	17
16	Cellular and plasma viral load in patients infected with HIV-2 1993 ·AIDS ·François Simon, Sophie Matheron, Catherine Tamalet, Ibtissam Loussert-Ajaka, (unknown), (unknown), Catherine Dhiver, (unknown), Carole Elbim, (unknown), Adrien G. Saimot, Françoise Brun‐Vézinet	140
17	Algorithmes du diagnostic sérologique des infections par VIH-1 et VIH-2 1992 ·Cahiers d'études et de recherches francophones / Santé ·François Simon, (unknown), (unknown), (unknown), (unknown), Sophie Matheron, Françoise Brun‐Vézinet	1
18	[Human immunodeficiency virus (HIV) infection in Mali]. 1989 ·PubMed ·É. Pichard, (unknown), (unknown), (unknown), (unknown), (unknown), Sékou F. Traorè, (unknown), Françoise Brun‐Vézinet, M. Rosenheim	5
19	Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature. 1987 ·Gut ·Dominique Roulot, Dominique Valla, Françoise Brun‐Vézinet, M.A. Rey, F Clavel, (unknown), (unknown), (unknown), B Rueff, J P Benhamou	24
20	Neuropathie périphérique en relation avec l'infection par le rétrovirus LAV/HTLV III. Etude clinique, anatomique et immunologique. Cinq observations. 1987 ·La Presse Médicale ·C. Leport, Marie‐Pierre Chaunu, (unknown), Françoise Brun‐Vézinet, J J Hauw, J. L. Vildé	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact